Neuroprotection: Lessons from a Spectrum of Neurological Disorders
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Evidence exists of direct anti-inflammatory effects of minocycline in the brain in many neurodegenerative and neurobehavioral diseases.
“Furthermore, evidence also exists of direct anti-inflammatory effects of minocycline in the brain in many neurodegenerative and neurobehavioral diseases54, 55.”
From Gut Dysbiosis Is Linked to Hypertension (2015) · cites this paper as [54]
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654 · see citing works
Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.
Nozari, A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012689 · Cited by 8,538 · see citing works
Intra-arterial Prourokinase for Acute Ischemic Stroke
Furlan, A. J., Higashida, R. T., Wechsler, L. R., Gent, M., Rowley, H. A., Kase, C. S., Pessin, M. S., Ahuja, A., Callahan, F., Clark, W. M., et al. (1999) · JAMA · doi:10.1001/jama.282.21.2003 · Cited by 3,050 · see citing works
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
Mayer, S. A., Brun, N. C., Begtrup, K., Broderick, J. P., Davis, S. M., Diringer, M. N., Skolnick, B. E., & Steiner, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042991 · Cited by 1,159 · see citing works
Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke
Alexandrov, A. V., Molina, C. A., Grotta, J. C., Garami, Z. F., Ford, S. R., Álvarez‐Sabín, J., Montaner, J., Saqqur, M., Demchuk, A. M., Moyé, L. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041175 · Cited by 1,043 · see citing works
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
Mayer, S. A. (2007) · Stroke · doi:10.1161/01.str.0000254499.46122.22 · Cited by 1,027 · see citing works
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)
Hacke, W., Albers, G. W., Al‐Rawi, Y., Bogousslavsky, J., Dávalos, A., Eliasziw, M., Fischer, M., Furlan, A. J., Kaste, M., Lees, K. R., et al. (2004) · Stroke · doi:10.1161/01.str.0000149938.08731.2c · Cited by 1,015 · see citing works
Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease
The Parkinson Study Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198911163212004 · Cited by 912 · see citing works
Energetics in the pathogenesis of neurodegenerative diseases
Beal, M. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01584-8 · Cited by 472 · see citing works
The NINDS NET-PD Investigators (2006) · Neurology · doi:10.1212/01.wnl.0000201252.57661.e1 · Cited by 453 · see citing works
Neuroprotection in Parkinson Disease
Schapira, A. H. V., & Olanow, C. W. (2004) · JAMA · doi:10.1001/jama.291.3.358 · Cited by 290 · see citing works
A Pilot Study of Normobaric Oxygen Therapy in Acute Ischemic Stroke
Singhal, A. B., Benner, T., Roccatagliata, L., Koroshetz, W. J., Schaefer, P. W., Lo, E. H., Buonanno, F. S., González, R. G., & Sorensen, A. G. (2005) · Stroke · doi:10.1161/01.str.0000158914.66827.2e · Cited by 279 · see citing works
Self-citationTrends in Acute Ischemic Stroke Trials Through the 20th Century
Kidwell, C. S., Liebeskind, D. S., Starkman, S., & Saver, J. L. (2001) · Stroke · doi:10.1161/01.str.32.6.1349 · Cited by 240 · see citing works
Tilley, B. C., Marler, J. R., Geller, N. L., Lü, M., Legler, J. M., Brott, T. G., Lyden, P. D., & Grotta, J. C. (1996) · Stroke · doi:10.1161/01.str.27.11.2136 · Cited by 227 · see citing works
Klivènyi, P., Kiaei, M., Gardian, G., Calingasan, N. Y., & Beal, M. F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02160.x · Cited by 201 · see citing works
tPA and Proteolysis in the Neurovascular Unit
Lo, E. H., Broderick, J. P., & Moskowitz, M. A. (2004) · Stroke · doi:10.1161/01.str.0000115164.80010.8a · Cited by 197 · see citing works
Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS
Zhang, W., Narayanan, M. V., & Friedlander, R. M. (2003) · Annals of Neurology · doi:10.1002/ana.10476 · Cited by 185 · see citing works
Fisher, M. (2005) · Stroke · doi:10.1161/01.str.0000173403.60553.27 · Cited by 156 · see citing works
Calcium antagonists for aneurysmal subarachnoid haemorrhage
Rinkel, G. J. E., Feigin, V. L., Algra, A., et al. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000277.pub2 · Cited by 111 · see citing works
Pilot Dose-Escalation Study of Caffeine Plus Ethanol (Caffeinol) in Acute Ischemic Stroke
Piriyawat, P., Labiche, L. A., Burgin, W. S., et al. (2003) · Stroke · doi:10.1161/01.str.0000067706.23777.04 · Cited by 68 · see citing works
Holloway, R. G., & Dick, A. W. (2002) · Neurology · doi:10.1212/wnl.58.5.679 · Cited by 44 · see citing works
Bakshi, R., Hutton, G. J., Miller, J. R., & Radue, E. (2004) · Neurology · doi:10.1212/wnl.63.11_suppl_5.s3 · Cited by 44 · see citing works
Advances in Stroke Neuroprotection: Hyperoxia and Beyond
Singhal, A. B., Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.08.014 · Cited by 21 · see citing works
Self-citationNINDS-Sponsored Clinical Trials in Stroke: Past, Present, and Future
Marler, J. R. (2002) · Stroke · doi:10.1161/str.33.1.311 · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Gut Dysbiosis Is Linked to Hypertension
Yang, T., Santisteban, M. M., Rodriguez, V., Li, E., Ahmari, N., Carvajal, J. M., Zadeh, M., Gong, M., Qi, Y., Zubcevic, J., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05315 · Cited by 1,478 · see citing works
A pilot open-label trial of minocycline in patients with autism and regressive features
Pardo, C. A., Buckley, A., Thurm, A., Lee, L.-C., Azhagiri, A., Neville, D. M., & Swedo, S. E. (2013) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-5-9 · Cited by 58 · see citing works
- Authors
- Galpern, W. R., & Singhal, A. B.
- Affiliations
- National Institutes of Health (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Galpern, Wendy R.
- ORCID
- Singhal, Aneesh B.
- Venue
- International Journal of Stroke
- Publisher
- SAGE Publications
- Published
- 2006-05
- Volume
- 1
- Issue
- 2
- Pages
- 97-99
- ISSN
- 1747-4930 (ISSN-L)
- 1747-4949
- OpenAlex
- W2065121893
- Cited by
- 4
- References
- 24
- Citations by year
- 2015: 2 · 2013: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Stroke (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke
- Topics
- Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
- Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- neuroprotection, neurological disorders, stroke, neurodegeneration
- MeSH terms
- Humans, Nervous System Diseases, Neuroprotective Agents, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
